Publication Name	World Journal of Gastroenterology
Manuscript ID	88539
Country	China

Received	2023-09-27 15:56
Peer-Review Started	2023-09-27 15:57
First Decision by Editorial Office Director	2023-12-04 19:45
Return for Revision	2023-12-04 19:45
Revised	2023-12-16 17:45
Publication Fee Transferred
Second Decision by Editor	2024-01-08 03:12
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-01-08 07:15
Articles in Press	2024-01-08 07:15
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-20 16:09
Publish the Manuscript Online	2024-01-26 07:56

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Antiviral treatment standards for hepatitis B: An urgent need for expansion
Manuscript Source	Unsolicited Manuscript
All Author List	Zi-Hong Bao, Zhi-Kun Dai and Hao-Xian Tang
ORCID	Author(s) ORCID Number Zi-Hong Bao http://orcid.org/0000-0002-2857-5370 Zhi-Kun Dai http://orcid.org/0000-0002-7258-0134 Hao-Xian Tang http://orcid.org/0000-0002-4346-7159
Funding Agency and Grant Number
Corresponding Author	Hao-Xian Tang, MD, Doctor, Doctor, Medical College, Shantou University Medical College, No. 22 Xinling Road, Jinping District, Shantou 515041, Guangdong Province, China. 19hxtang@stu.edu.cn
Key Words	Hepatitis B virus; Chronic hepatitis B; Antiviral treatment criteria; Serum alanine aminotransferase; Liver-related mortality; Letter to the Editor
Core Tip	Chronic hepatitis B (CHB) is a serious public health problem. Early detection and effective antiviral treatment can remarkably reduce liver-related mortality caused by CHB. However, the global diagnosis and treatment rates of CHB are only 10% and 2%, respectively. Expanding the standard of antiviral treatment for patients with hepatitis B is urgently needed to improve cost-effectiveness and survival further.
Publish Date	2024-01-26 07:56
Citation	Bao ZH, Dai ZK, Tang HX. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World J Gastroenterol 2024; 30(4): 418-420
URL	https://www.wjgnet.com/1007-9327/full/v30/i4/418.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i4.418

Full Article (PDF)	WJG-30-418-with-cover.pdf
Full Article (Word)	WJG-30-418.docx
Manuscript File	88539_Auto_Edited-JLW.docx
Answering Reviewers	88539-Answering reviewers.pdf
Audio Core Tip	88539-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88539-Conflict-of-interest statement.pdf
Copyright License Agreement	88539-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88539-Language certificate.pdf
Peer-review Report	88539-Peer-review(s).pdf
Scientific Misconduct Check	88539-Bing-Li L-2.png
Scientific Editor Work List	88539-Scientific editor work list.pdf
CrossCheck Report	88539-CrossCheck report.pdf
CrossCheck Report	88539-CrossCheck.png